إعلان
إعلان
TERN
Terns Pharmaceuticals, Inc. Common Stock
40.14
USDبرعاية
-0.26
-0.65%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
40.27
+0.14
+0.35%
تقارير أرباح TERN
النسبة الإيجابية المفاجئة
TERN تفوق 16 من 20 آخر التقديرات.
80%
التقرير التالي
بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.29
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+7.41%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+20.83%
Terns Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ١٠ نوفمبر ٢٠٢٥, TERN reported earnings of -0.27 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 10.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analysts forecast an EPS of -0.29 USD, with revenue projected to reach -- USD, implying an increase of 7.41% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Terns Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Terns Pharmaceuticals, Inc. Common Stock reported EPS of -$0.27, beating estimates by 10.68%, and revenue of $0.00, 0% as expectations.
How did the market react to Terns Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 7.64%, changed from $19.12 before the earnings release to $20.58 the day after.
When is Terns Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
What are the forecasts for Terns Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 13
analysts, Terns Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.29 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان